The above findings elucidated the binding patterns and interaction modalities of quercetin with EPHA3, RASIP1, EFEMP2 and PPP1R15A, implying that these proteins may serve as pivotal targets for quercetin in the therapeutic intervention of T2DM and OA. The gene discussed is EPHA3; the disease is type 2 diabetes mellitus.